These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 20618924)

  • 1. Abnormalities in circulating plasmacytoid dendritic cells in patients with systemic lupus erythematosus.
    Jin O; Kavikondala S; Mok MY; Sun L; Gu J; Fu R; Chan A; Yeung J; Nie Y; Lau CS
    Arthritis Res Ther; 2010; 12(4):R137. PubMed ID: 20618924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysfunctional interferon-alpha production by peripheral plasmacytoid dendritic cells upon Toll-like receptor-9 stimulation in patients with systemic lupus erythematosus.
    Kwok SK; Lee JY; Park SH; Cho ML; Min SY; Park SH; Kim HY; Cho YG
    Arthritis Res Ther; 2008; 10(2):R29. PubMed ID: 18321389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-Regulation of TLR7-Mediated IFN-α Production by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus.
    Sakata K; Nakayamada S; Miyazaki Y; Kubo S; Ishii A; Nakano K; Tanaka Y
    Front Immunol; 2018; 9():1957. PubMed ID: 30210502
    [No Abstract]   [Full Text] [Related]  

  • 4. TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients.
    Wu P; Wu J; Liu S; Han X; Lu J; Shi Y; Wang J; Lu L; Cao X
    Clin Immunol; 2008 Oct; 129(1):40-8. PubMed ID: 18684674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgE Inhibits Toll-like Receptor 7- and Toll-like Receptor 9-Mediated Expression of Interferon-α by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus.
    Khoryati L; Augusto JF; Shipley E; Contin-Bordes C; Douchet I; Mitrovic S; Truchetet ME; Lazaro E; Duffau P; Couzi L; Jacquemin C; Barnetche T; Vacher P; Schaeverbeke T; Blanco P; Richez C;
    Arthritis Rheumatol; 2016 Sep; 68(9):2221-31. PubMed ID: 26991804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heightened TLR7/9-Induced IL-10 and CXCL13 Production with Dysregulated NF-ҝB Activation in CD11c
    Yim LY; Lau CS; Chan VS
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31546763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of Association Between Sex Hormones, MDSCs, LDGs and pDCs in Males and Females With Systemic Lupus Erythematosus.
    Jones JM; Smith F; Littlejohn E; Jorgensen TN
    Front Immunol; 2022; 13():888501. PubMed ID: 35833144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic lupus erythematosus patients have increased number of circulating plasmacytoid dendritic cells, but decreased myeloid dendritic cells with deficient CD83 expression.
    Jin O; Kavikondala S; Sun L; Fu R; Mok MY; Chan A; Yeung J; Lau CS
    Lupus; 2008 Jul; 17(7):654-62. PubMed ID: 18625638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells.
    Yan B; Ye S; Chen G; Kuang M; Shen N; Chen S
    Arthritis Rheum; 2008 Mar; 58(3):801-12. PubMed ID: 18311820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced IFN-α production is associated with increased TLR7 retention in the lysosomes of palasmacytoid dendritic cells in systemic lupus erythematosus.
    Murayama G; Furusawa N; Chiba A; Yamaji K; Tamura N; Miyake S
    Arthritis Res Ther; 2017 Oct; 19(1):234. PubMed ID: 29052537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A benzenediamine derivative fc-99 attenuates lupus-like syndrome in MRL/lpr mice related to suppression of pDC activation.
    Ji J; Fan H; Li F; Li X; Dong G; Gong W; Song Y; Liu F; Hua C; Tan R; Dou H; Hou Y
    Immunol Lett; 2015 Dec; 168(2):355-65. PubMed ID: 26545567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-regs in autoimmune hepatitis-systemic lupus erythematosus/mixed connective tissue disease overlap syndrome are functionally defective and display a Th1 cytokine profile.
    Longhi MS; Ma Y; Grant CR; Samyn M; Gordon P; Mieli-Vergani G; Vergani D
    J Autoimmun; 2013 Mar; 41():146-51. PubMed ID: 23287048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosus.
    Sacre K; Criswell LA; McCune JM
    Arthritis Res Ther; 2012 Jun; 14(3):R155. PubMed ID: 22734582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired TLR9 responses in B cells from patients with systemic lupus erythematosus.
    Gies V; Schickel JN; Jung S; Joublin A; Glauzy S; Knapp AM; Soley A; Poindron V; Guffroy A; Choi JY; Gottenberg JE; Anolik JH; Martin T; Soulas-Sprauel P; Meffre E; Korganow AS
    JCI Insight; 2018 Mar; 3(5):. PubMed ID: 29515028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Ets-1 and FOXP3 mRNA in CD4(+)CD25 (+) T regulatory cells from patients with systemic lupus erythematosus.
    Xiang N; Li XP; Li XM; Wang GS; Tao JH; Pan HF; Fang X; Ma Q; Yu N
    Clin Exp Med; 2014 Nov; 14(4):375-81. PubMed ID: 24221578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two separate effects contribute to regulatory T cell defect in systemic lupus erythematosus patients and their unaffected relatives.
    Costa N; Marques O; Godinho SI; Carvalho C; Leal B; Figueiredo AM; Vasconcelos C; Marinho A; Moraes-Fontes MF; Gomes da Costa A; Ponte C; Campanilho-Marques R; Cóias T; Martins AR; Viana JF; Lima M; Martins B; Fesel C
    Clin Exp Immunol; 2017 Sep; 189(3):318-330. PubMed ID: 28542701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic and functional analysis of CD4+ CD25- Foxp3+ T cells in patients with systemic lupus erythematosus.
    Bonelli M; Savitskaya A; Steiner CW; Rath E; Smolen JS; Scheinecker C
    J Immunol; 2009 Feb; 182(3):1689-95. PubMed ID: 19155519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cytotoxic anti-IL-3Rα antibody targets key cells and cytokines implicated in systemic lupus erythematosus.
    Oon S; Huynh H; Tai TY; Ng M; Monaghan K; Biondo M; Vairo G; Maraskovsky E; Nash AD; Wicks IP; Wilson NJ
    JCI Insight; 2016 May; 1(6):e86131. PubMed ID: 27699260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine production by activated plasmacytoid dendritic cells and natural killer cells is suppressed by an IRAK4 inhibitor.
    Hjorton K; Hagberg N; Israelsson E; Jinton L; Berggren O; Sandling JK; Thörn K; Mo J; ; Eloranta ML; Rönnblom L
    Arthritis Res Ther; 2018 Oct; 20(1):238. PubMed ID: 30355354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative and qualitative normal regulatory T cells are not capable of inducing suppression in SLE patients due to T-cell resistance.
    Vargas-Rojas MI; Crispín JC; Richaud-Patin Y; Alcocer-Varela J
    Lupus; 2008 Apr; 17(4):289-94. PubMed ID: 18413409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.